Mirum Company Profile
What is the competitive landscape for MIRUM
MIRUM has five approved drugs.
There are ten US patents protecting MIRUM drugs.
Summary for Mirum
| US Patents: | 10 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 5 |
Drugs and US Patents for Mirum
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mirum | CTEXLI | chenodiol | TABLET;ORAL | 219488-001 | Feb 21, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Mirum | LIVMARLI | maralixibat chloride | TABLET;ORAL | 219485-004 | Apr 10, 2025 | RX | Yes | Yes | 11,229,647 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mirum | LIVMARLI | maralixibat chloride | TABLET;ORAL | 219485-003 | Apr 10, 2025 | RX | Yes | Yes | 11,376,251 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mirum | LIVMARLI | maralixibat chloride | TABLET;ORAL | 219485-003 | Apr 10, 2025 | RX | Yes | Yes | 11,260,053 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mirum | LIVMARLI | maralixibat chloride | TABLET;ORAL | 219485-002 | Apr 10, 2025 | RX | Yes | Yes | 12,350,267 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mirum | LIVMARLI | maralixibat chloride | TABLET;ORAL | 219485-001 | Apr 10, 2025 | RX | Yes | Yes | 11,376,251 | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Mirum Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Croatia | P20241088 | ⤷ Start Trial |
| South Korea | 20140084304 | ⤷ Start Trial |
| Mexico | 2021009625 | ⤷ Start Trial |
| Israel | 285494 | ⤷ Start Trial |
| Denmark | 2771003 | ⤷ Start Trial |
| Japan | 2022070878 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Mirum Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2771003 | 122023000029 | Germany | ⤷ Start Trial | PRODUCT NAME: MARALIXIBAT ODER EIN PHARMAZEUTISCH AKZEPTABLES SALZ DAVON, INSBESONDERE MARALIXIBATCHLORID; REGISTRATION NO/DATE: EU/1/22/1704 20221209 |
| 2771003 | 21/2023 | Austria | ⤷ Start Trial | PRODUCT NAME: MARALIXIBAT ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON, INSBESONDERE MARALIXIBATCHLORID; REGISTRATION NO/DATE: EU/1/22/1704 (MITTEILUNG) 20221212 |
| 2771003 | CA 2023 00017 | Denmark | ⤷ Start Trial | PRODUCT NAME: MARALIXIBAT ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, ISAER MARALIXIBATCHLORID; REG. NO/DATE: EU/1/22/1704 20221212 |
| 2380576 | 2020/043 | Ireland | ⤷ Start Trial | PRODUCT NAME: DEOXYCHOLIC ACID SODIUM SALT; NAT REGISTRATION NO/DATE: PA2103/003/001 20170602; FIRST REGISTRATION NO/DATE: SE/H/1547/001/DC 20160729 |
| 1392714 | CA 2017 00025 | Denmark | ⤷ Start Trial | PRODUCT NAME: OBETICHOLIC ACID; REG. NO/DATE: EU/1/16/1139 20161215 |
| 2771003 | C02771003/01 | Switzerland | ⤷ Start Trial | PRODUCT NAME: MARALIXIBAT; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 69201 18.07.2024 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
